General Information of Drug (ID: DMUZNF0)

Drug Name
Tridolgosir
Synonyms
Swainsonine; Swainsonine hydrochloride; Tridolgosir hydrochloride; Carbohydrate processing inhibitors, GLYCODesign; GD-0039; Transforming growth factor beta inhibitors, GLYCODesign; GD-0039 analogs, GlycoDESIGN
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 173.21
Logarithm of the Partition Coefficient (xlogp) -1.3
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 4
Adverse Drug Reaction (ADR)
ADR Term Variation Related DOT DOT ID REF
Metastases to liver Not Available MAN2B1 OTL062QO [2]
Skin and subcutaneous tissue disorders Not Available MAN2A1 OTPM5EAH [2]
Chemical Identifiers
Formula
C8H15NO3
IUPAC Name
(1S,2R,8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,2,8-triol
Canonical SMILES
C1C[C@H]([C@@H]2[C@@H]([C@@H](CN2C1)O)O)O
InChI
InChI=1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6-,7-,8-/m1/s1
InChIKey
FXUAIOOAOAVCGD-WCTZXXKLSA-N
Cross-matching ID
PubChem CID
51683
ChEBI ID
CHEBI:9367
CAS Number
72741-87-8
DrugBank ID
DB02034
TTD ID
D0S1AD

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Golgi alpha-mannosidase II (MAN2A1) TT34DCN MA2A1_HUMAN Inhibitor [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Alpha-mannosidase 2 (MAN2A1) OTPM5EAH MA2A1_HUMAN Drug Response [2]
Lysosomal alpha-mannosidase (MAN2B1) OTL062QO MA2B1_HUMAN Drug Response [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010383)
2 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010383)